Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M204176200 on August 22, 2002

J. Biol. Chem., Vol. 277, Issue 44, 41455-41462, November 1, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/44/41455    most recent
M204176200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuyama, R.
Right arrow Articles by Fushiki, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuyama, R.
Right arrow Articles by Fushiki, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Newly Established Neuronal rho -0 Cell Line Highly Susceptible to Oxidative Stress Accumulates Iron and Other Metals

RELEVANCE TO THE ORIGIN OF METAL ION DEPOSITS IN BRAINS WITH NEURODEGENERATIVE DISORDERS*

Ryuichi FukuyamaDagger §, Akihiko Nakayama, Taizen NakaseDagger , Hiroe TobaDagger ||, Teruo Mukainaka**, Hirofumi SakaguchiDagger Dagger Dagger , Takuya SaiwakiDagger §§, Hiromu Sakurai, Mikio WadaDagger , and Shinji FushikiDagger

From the Dagger  Department of Pathology and Applied Neurobiology, Research Institute for Neurological Diseases and Geriatrics, the ** Central Laboratory, and the Dagger Dagger  Department of Otolaryngology, Kyoto Prefectural University of Medicine, 465 Kawaramachi Hirokoji, Kamigyo-ku, Kyoto 602-8566 and the Departments of  Analytical and Bioinorganic Chemistry and || Clinical Pharmacology, Kyoto Pharmaceutical University, 5 Misasagi Nakauchi-cho, Yamashina-ku, Kyoto 607-8414, Japan

Received for publication, April 29, 2002, and in revised form, August 5, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

From human neuroblastoma-derived SILA cells we have established a rho -0 cell line that is deficient in both respiration and mitochondrial DNA. Lactate dehydrogenase activity, lactate production, and growth in the medium without glucose indicate that these cells shift from aerobic to anaerobic metabolism. Electron microscopic observations revealed abnormal mitochondria with unique cristae structures. Staining with MitoTracker dye showed that the mitochondrial transmembrane potential was reduced by 30-40% from the parent cell levels. These cells were markedly susceptible to H2O2 and died apparently by a necrotic mechanism, a process blocked by deferoxamine in the parent cells but not rho -0 cells. Analysis by inductively coupled plasma-mass spectrometry revealed an approximately 3-fold accumulation of iron in the rho -0 cells at confluence (n = 4-6, three clones, *p < 0.05). Iron and four other metals were all elevated in the cells of one of the rho -0 clones and were similar to control levels in the control cybrid cells, which were replenished with normal mitochondrial DNA. Their sensitivity to H2O2 was also similar to that of the parent cells. These results indicate that a newly established neuronal related rho -0 cell line is highly susceptible to active oxygen species and that these toxicity effects appear to be related to an accumulation of transition metals, which probably occurs through the respiratory impairment.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Iron and other transition metals exacerbate and in some cases initiate the degeneration of neurons (e.g. 1-3) through the Fenton reaction (4). In the brain of patients with Alzheimer's disease (AD),1 an increase in the content of iron (5-9) and aluminum (4, 7) has been reported, and treatment of AD patients with iron chelators has been discussed (10). In the brain of patients with Parkinson's disease and Huntington's disease, iron and other metals also appear to accumulate (8, 11). It is important to note that all of these diseases show mitochondrial abnormalities to some extent (12-19), suggesting a coupling of metal accumulation with mitochondrial deficiency. More direct evidence of mitochondrial and iron association in neurodegenerative disorders comes from an increase in mitochondrial iron in the fibroblasts of patients with Friedreich's ataxia, whose responsible gene is the mitochondrial frataxin (3, 20, 21). It would also be intriguing to uncover an association of mitochondrial respiratory deficiency and cell death with an accumulation of metals because a new, pivotal, regulatory role for mitochondria in cell survival and death has emerged from a growing body of evidence (for a review, see Ref. 22).

We considered mtDNA-depleted rho  (rho)-0 cells (23) to be a useful cellular model in an analysis of the consequences of chronic mitochondrial impairment and decreased respiration. These cells have served as a recipient for diseased mtDNAs (13, 24, 25) and are a valuable cellular tool for analyzing the coupling between cellular phenotypes and chronic respiratory deficiency (26-28) and for searching for genes coupled to the respiration-deficient status (29, 30). Generation of such rho -0 cell types that have a neuronal background appears difficult because neuronal and glial cells are susceptible to respiratory crisis, and only one human neuroblastoma-derived rho -0 line is available (SH-SY5Y origin (31)).

In this report, first we established a novel rho -0 line from a human neuroblastoma line, characterized it, and discovered that its phenotype might be relevant to mitochondrial and neurodegenerative disorders. We then examined whether these cells are vulnerable to oxidative stress through a metal-mediated mechanism. The present results strongly suggest that chronic deficiency in the mitochondrial respiration of cells produces an accumulation of iron and other metals, rendering them highly susceptible to oxidative stress.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Type, Ethidium Bromide (EtBr) Treatment, and Establishment of rho -0 Lines-- The SILA cell line was initially isolated from a child's neuroblastoma by Matsumura et al. (32) at our university. These cells produced neuronal and epithelial subtypes in vitro, but we employed a neuronal type 2B4 subline in this study (provided by Dr. Matsumura). SILA cells were grown in Dulbecco's modified Eagle's medium (high glucose, 4.5 g/liter, Nacalai Tesque, Inc., Kyoto, Japan) supplemented with 10% fetal calf serum. For establishing rho -0 cells, pyruvate and uridine were also added to the medium at the reported concentrations (31). Initially, cells were treated with EtBr (Bio-Rad) at different concentrations ranging from 0.25 to 10 µg/ml, and those concentrations, at which cells showed no morphological response or immediate death, were excluded from the subsequent experiment. When most of the SILA cells remaining in the culture started to grow continuously after a few months of EtBr treatment, we subcloned them either by limiting dilution or cloning rings. Cloned cells were maintained in the culture medium supplemented with pyruvate, uridine, and 1 µg/ml EtBr for the next month. We monitored respiration of cells periodically as described below. After ~10 passages, EtBr-resistant and respiration-deficient cells were used for subsequent experiments.

O2 Consumption-- Cells at confluence in a 10-cm diameter dish were detached and suspended in 10 ml of Tyrode's solution (+), which consisted of 0.134 M NaCl, 3 mM KCl, 3 mM NaH2PO4, 2 mM MgCl2, 5 mM Hepes, 5 mM glucose, 12 mM NaHCO3, 1 mM EGTA, and 3.5 mg/ml bovine serum albumin, pH 6.5. Then, the cells were collected, and a certain number of them, ~4 -10 × 106, were resuspended in 1.2 ml of Tyrode's solution (-), pH 7.4, which omitted EGTA from Tyrode's solution (+). Cells were then transferred to the chamber of the device (Oxigraph type 9, Central Science, Co., Ltd., Tokyo, Japan), which was equipped with the Clarke-type electrode to measure the rate of O2 consumption polarographically, and O2 consumption was calculated using the following formula: rate of O2 consumption (in fmol/min/cell) = (the rate of O2 consumption of cells (in mg/liter/min) - the rate of decrease of O2 concentration of Tyrode's solution (-) (in mg/liter/min)) × 1.2 (ml) × 10-15 (fmol)/32 (g)/cell number, where the volume of the chamber is 1.2 ml and the molecular weight of O2 is 32.

PCR in Determining Mitochondrial DNA-- A portion of the D-loop region of mtDNA was amplified using serially diluted DNA samples isolated from the parent and three representative rho -0 clones. The intensities of these amplified bands in gel visualized with EtBr were compared with those of the nuclear DNA-encoded beta -actin gene. The primer sequences listed below were derived from those reported previously (33, 34) and from GenBank; human D-loop (390 bp): forward, 5'-GATCACAGGTCTATCACCCT-3'; reverse, 5'-ATCTGGTTAGGCTGGTGTTA-3'; human beta -actin (298 bp): forward, 5'-ACCATGTACCCTGGCATTGCCG-3'; reverse, 5'-CCATGCCAATCTCATCTTGT TT-3' (numbers in parentheses are the sizes of PCR-amplified DNA fragments in bp).

Lactate Release, LDH Activity, ATP Level, and Total Reduced Glutathione (GSH)-- Lactate concentrations in the culture media were measured with a commercially available kit (L-Lactic acid, Roche Molecular Biochemicals), and the rate of the production, which was expressed in µg/h/mg of protein, was calculated according to the manufacturer's instructions. Cellular LDH activity and the GSH level were also determined with commercially available kits (LDH-D, Nissui Pharmaceutical Co., Ltd., Tokyo; BIOTECH GSH-400 OXIS, International, Inc., Portland, OR) and expressed in units/mg and nmol/mg, respectively. The ATP level was measured by a chemiluminescent reaction-based method using a kit (Compactlumi VS501, Yamato Science, Tokyo), and the luminescence was detected using a luminometer (Gene-Light55, Microtech Nichion, Tokyo). ATP levels were calculated and expressed in pmol/mg. All values were normalized with the total protein as above, which was determined using bicinchoninic acid reagent (BCA Protein Assay Reagent Kit, Pierce Chemical Co.).

Dependence of rho -0 Cells on Pyruvate, Uridine, and Glucose-- To confirm the dependence of their growth on the supplementation of pyruvate and uridine, cell growth was monitored by the trypan blue exclusion method over 5 days in culture with or without these substrates. The dependence of energy metabolism on glucose was evaluated by counting cells in 3-cm diameter dishes for 24 h in galactose-substituted (for glucose) medium and by comparing cellular ATP and lactate production (as described above).

Delta Psi m-sensitive MitoTracker Staining-- Cells cultured in wells of a 24-well plate in which glass coverslips were placed were labeled with MitoTracker dye (CMTMRos, Molecular Probes, Eugene, OR) at 100 nM for 15 min, postfixed with 4% paraformaldehyde solution (0.01 M phosphate buffer, pH 7.4), and observed using a fluorescent microscope (ECLIPS E1000, Nikon, Kyoto) with a red filter for interference (>=  590 nm). Fluorescent intensities in the unit area of the cytoplasm and nucleus of SILA and Srho -0 cells were measured densitometrically, and from these values, the intensity of the glass slide was subtracted as a background. The fluorescent intensity of the nucleus was used to normalize intercellular and interexperimental differences in MitoTracker staining. Products obtained by dividing the intensity of cytoplasmic fluorescence with that of nucleic fluorescence were calculated (n = 10-12 cells) and statistically compared.

Electron Microscopy-- We observed three clones of the Srho -0 line, clone 1-6, 4-2, and 6H10, under electron microscopy. Cells at confluence in a T75 flask were fixed with 2% glutaraldehyde for 30 min and collected from the flask with a scraper. They were postfixed with 1% OsO4 and embedded in epoxy resin. Ultrathin sections were stained with uranic acetate and lead and observed with a H7000 electron microscope (Hitachi Co. Ltd., Tokyo).

H2O2 Stress and Effect of an Iron/Copper Chelator-- For this experiment, we used the clone 4-2 from three Srho -0 lines because its ATP level was similar to that of the parent cells. Cells grown in 3-cm diameter dishes were incubated with H2O2 (analytical grade for atomic absorption, Wako Pure Chemical Industries, Kyoto) at various concentrations with or without deferoxamine mesylate (DFX, Wako) for 24 h. 10 µl of culture medium from each dish was then incubated with substrate solution for determining LDH activity released from cells with the above described kit (LDH-D). Meanwhile, cells in the dish were lysed with lysis buffer (5 mM Tris/HCl, pH 7.4) containing 0.5% Triton X-100 and 20 mM EDTA, and the total DNA was extracted with phenol. DNA precipitated with ethanol and dissolved in Tris/EDTA buffer was incubated with RNase A (Sigma) at 100 µg/ml for 1 h, extracted again with phenol, precipitated with ethanol, and electrophoresed in 2.2% agarose gel.

Determination of Metals-- To measure the total cellular metals, control and rho -0 cells grown in and confluent at 10-cm diameter dishes were detached with trypsin, washed twice with phosphate buffer that included mannitol at 0.25 M, and then were completely reduced to ash by treatment with nitric acid (for poisonous metal determination, Wako), hydrogen peroxide (for atomic absorption spectrochemical analysis, Wako), and perchloric acid (for poisonous metal determination, Wako) under heat (8, 35). Cellular ashes were dissolved with 10 ml of 6% nitric acid and then analyzed by inductively coupled plasma-mass spectrometry (ICP-MS) using a Shimadzu ICPS-8500 (Shimadzu, Kyoto, Japan). We first measured the iron content (m/z 57) in three representative Srho -0 clones to confirm that an accumulation of iron in this cell type was general. Then, we established a control cybrid line (see below) and measured the levels of four other metals, aluminum (m/z 27), manganese (m/z 55), copper (m/z 63), and zinc (m/z 66) together with iron, in the parent SILA, Srho -0, and the control cybrid cells. We selected these metals because they are the major transition metals within cells. Contamination from tubes and other sources was avoided for these metals. The concentration of cellular metals was calculated according to a linearly regressed curve prepared for each metal using a standard solution (Multielement Standard Solution BM, Wako). Values of a serially diluted multielement standard solution showed linear regression with a line in the range from 5 to 1,000 ng/ml for aluminum, iron, and zinc and from 0.5 to 100 ng/ml for copper and manganese, respectively. The measurement was performed at least twice (n = 3-4) to verify the results.

Production of Normal Cybrid Cells and Sensitivity to Oxidative Stress-- To clarify whether an elevation of metal contents in Srho -0 cells is mtDNA-dependent, we produced a cybrid cell line replenished with normal mtDNA by fusing rho -0 cells with platelets from a normal volunteer (23-year-old Japanese female) by the standard protocol (24, 25). The mtDNA level and the metabolic shift were evaluated by the PCR procedure and by lactate production as described above, respectively. We succeeded in producing the control cybrids from Srho -0 clones 1-6 and 6H10 and used Srho -0/1-6 and its corresponding control cybrid cells for determination of the five metals. To assess the sensitivity of parent, Srho -0/1-6, and the control cybrid cells to oxidative stress, the cells were incubated individually with H2O2 at 0.5 mM for 24 h because the results obtained in the earlier experiment (see above) indicated that this concentration of H2O2 was critical for evaluating its effect. The LDH activity released to culture media from cells thus treated was measured as discussed previously.

Statistical Analysis-- Using an appropriate computer program (Win Stat, version 1.2, Abacus Concepts, Berkeley, CA), we compared two groups and multigroups with the unpaired t test and ANOVA with Bonferroni's multiple comparison, respectively. Significance was set at p < 0.05.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Establishment of Srho -0 Lines-- In initial experiments, we determined the range of appropriate concentrations of EtBr in the medium to be from 1 to 10 µg/ml, as reported previously (31). SILA cells were markedly resistant to EtBr toxicity and were able to grow even at the highest concentration. Subsequently, more than 10 clones were isolated, termed Srho -0, and we used three Srho -0 clones for subsequent analysis. The rate of O2 consumption of the parent line was 0.56 ± 0.18 fmol/min/cell (n = 3), whereas that of the Srho -0 cells was immeasurable (Table I). Targeting 3 ng and 30 pg (corresponding to 1 and 10-2 in Fig. 1) of the total DNA isolated from SILA cells, portions of both the D-loop region of mtDNA and beta -actin gene were amplified by PCR. When the lowest quantity of the genomic DNA, 0.3 pg (10-4), was used, the fragment of the D-loop region still was produced, but the beta -actin fragment was not (Fig. 1, SILA). The sensitivity of this determination was therefore calculated as a few copies of a gene, given that the DNA quantity of a single cell comprises 6 pg (2 (diploid) × 3 × 109 (bp/haploid of a human genome) × 600 (molecular weight/bp)/6 × 1023). While using DNA samples isolated from Srho -0 clones, regardless of the quantities, no D-loop region-derived bands were detectable (Fig. 1, e.g. Srho -0 clones 1-6 and 4-2). We examined all other clones in the same way, and we periodically performed PCR using DNA samples as 10 ng (see also production of control cybrids).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Biochemical characterization
O2 consumption, LDH activity, lactate production, ATP level, and total GSH level of SILA and three representative clones of Srho -0 lines 1-6, 4-2, and 6H10 (mean ± S.D., n = 3-4) were measured as described under "Experimental Procedures." *** indicates significance at p < 0.001 in ANOVA with Bonferroni's correction. ND, not detected.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   Determination of the mtDNA level. Determination of the level of mtDNA in SILA and two representative clones of the Srho -0 line is shown. Numbers at the top (1, 10-2, 10-4) indicate dilution factors of the DNA samples used in PCR amplification with the starting concentration of the total DNA as 3 ng. D-loop and actin indicate the D-loop region of human mtDNA and the nuclear DNA-encoded beta -actin. PCR products were electrophoresed in 1.5% agarose gel, which was subsequently stained with EtBr bromide and photographed. m indicates the 100-bp ladders with an intensified band at 500 bp.

Biochemical Characterization of Srho -0 Cells-- The LDH activity of two clones of Srho -0 cells (Table I; Srho -0/1-6 and Srho -0/4-2) were increased slightly, whereas that of the other clone (Srho -0/6H10) was increased significantly (n = 3-4, ***, p < 0.0001) compared with parent SILA cells. Lactate release of all three Srho -0 clones was significantly higher than that of the parent cells (***, p < 0.001). The ATP levels of clones 1-6 and 4-2 were not decreased significantly from those of SILA cells, and those of clone 6H10 were increased 60% (***, p < 0.0001). The levels of GSH in three Srho -0 clones were all similar to the level of the parent cells.

Dependence on Pyruvate and Uridine, and Glycolytic Shift-- Replacement of glucose with galactose in the culture medium significantly reduced the cell number, lactate production, and the level of ATP of rho -0 cells (Fig. 2, n = 3, *, p < 0.05, ***, p < 0.0001). Without pyruvate and uridine in the culture medium, Srho -0 cells did not grow (Fig. 2, cell growth, open circles, n = 3) and were dead by 1 week (data not shown). When pyruvate and uridine were added, the cells grew constantly over 5 days (Fig. 2, closed circles, n = 3). All three Srho -0 clones showed similar results.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of substitution of glucose with galactose in the culture medium. Srho -0 clone 4-2 cells were cultured in the 3-cm diameter dishes, and at confluence the medium was replaced with fresh medium supplemented with either glucose or galactose. After 24 h, the cell number was counted by the trypan blue exclusion method, and the lactate production and ATP level were measured with kits as described under "Experimental Procedures." Error bars indicate the means ± S.E.; * and *** indicate p < 0.05 and 0.001, respectively. To evaluate the growth pattern in the medium with (closed circles) or without (open circles) pyruvate and uridine, ~1 × 106 cells were plated in 3-cm diameter dishes on day 0 and allowed to grow for the next 5 days (n = 3). Growth curves indicate that they were unable to grow without these substrates.

Electron Microscopic Observation-- SILA cells contained normal mitochondria with an electron-dense matrix and regular cristae structure (Fig. 3A), whereas all Srho -0 cells contained only swollen mitochondria with a translucent matrix, which were not observed in parent cells (Fig. 3, B-D). The morphology of cristae was markedly varied, short, extended, and circular. Occasionally, mitochondria with onion-shaped, concentric multilamellae cristae (Fig. 3D, arrows) were observed regardless of Srho -0 clones.


View larger version (138K):
[in this window]
[in a new window]
 
Fig. 3.   Electron microscopy of Srho -0 cells. Cells at about 80% confluence in T75 flasks were fixed with 2% glutaraldehyde and then collected with a scraper. Cells were postfixed, stained with uranic acetate and lead, and observed under an electron microscope. A, regular shaped, electron-dense mitochondria with a regular cristae structure are observed in SILA cells. B, Srho -0/1-6 cells contain enlarged mitochondria with a translucent matrix and extended cristae. C, only swollen mitochondria with quite irregular cristae and translucent matrix are observed in Srho -0/6H10 cells. D, they often contain concentric multilamellar mitochondria (arrows). The scale bar in D indicates 1.2 µm for A, 1.5 µm for B, 2.7 µm for C, and 2.1 µm for D.

MitoTracker Staining for Delta Psi m-- The mitochondrial structure in SILA cells was clearly stained with CMTMRos (Fig. 4A), whereas in Srho -0 cells the amorphous structure was only stained weakly (Fig. 4B). Determination of the red fluorescent intensity of CMTMRos incorporated into mitochondria of SILA and two clones of Srho -0 cells demonstrated a 30-40% reduction in rho -0 cells compared with controls (Fig. 4C, n = 10-12 cells, ***, p < 0.0001).


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 4.   Vital staining of cells with MitoTracker dye. Cells were plated in 3-cm diameter dishes in which cover slips were placed and then incubated with CMTMRos for 15 min and fixed. They were observed under a computer-assisted fluorescent microscope. We examined two Srho -0 clones, 1-6 and 4-2, in this experiment. A, SILA. B, Srho -0/4-2. The white bar in B is 2 µm. C, fluorescent intensity at the slide glass was subtracted as the background from that of each unit area of cytoplasm and of the nucleus of the same cell (n = 10-12). The cytoplasmic fluorescent intensities of SILA (open bar) and Srho -0 (closed bars) cells are shown in value relative to those of nucleic fluorescence of the corresponding cells (y axis). Error bars indicate the means ± S.E. (ANOVA with Bonferroni's multiple comparison, ***p < 0.0001). Note that the signal intensity of B was artificially enhanced so that the morphology of the stained mitochondria would be visible.

Oxidative Stress and Effect of an Iron/Copper Chelator-- Parent cells were affected when treated with H2O2 in a dose-dependent manner as evidenced by an elevation of LDH activity in the medium (Fig. 5A, SILA, n = 3, ***, p < 0.0001, versus without H2O2 treatment, open bar). The electrophoresed DNA of SILA cells showed a ladder pattern in a corresponding way (Fig. 5B, left half). The LDH release from Srho -0/4-2 cells into the culture medium occurred by the addition of H2O2 even at 0.25 mM and had already reached the maximum at 0.5 mM (Fig. 5A, Srho -0, n = 3). DNA isolated from the Srho -0/4-2 cells treated with H2O2 showed a smear in gel in a dose-dependent manner (Fig. 5B, right half). When SILA cells were treated with DFX, an iron/copper chelator (43), together with H2O2, both the LDH release (Fig. 5C, SILA, n = 3, ***, p < 0.0001 and **, p < 0.001, versus without H2O2 treatment, open bar) and DNA fragmentation (Fig. 5D, left half) were completely abolished in a dose-dependent manner. On the other hand, the DFX treatment up to 500 µM had no inhibitory effect on either the LDH release from Srho -0/4-2 cells (Fig. 5C, Srho -0, n = 3) or the smear DNA pattern (Fig. 5D, right half).


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 5.   Determination of LDH release, the DNA electrophoretic pattern, and dose-response effect of DFX against H2O2-induced cell death. Cells confluent in 3-cm diameter dishes received fresh medium with or without H2O2. A, the levels of LDH release into culture media from SILA (left half) and Srho -0/4-2 (right half) cells after treatment with H2O2 at various concentrations (0-2 mM) for 24 h (n = 3, mean ± S.D.) are shown. The numbers on the y axis indicate LDH activity (in milliunits), and the numbers between A and B indicate the H2O2 concentration in the media (0-2 mM). *** indicates a significant increase in the LDH activity at p < 0.0001 compared with that of cells without H2O2. B, after the medium was removed, cells in the dish were washed, lysed with lysis buffer, and DNA was precipitated with ethanol. Isolated DNA was electrophoresed in 2.2% agarose gel. Left, SILA; right, Srho -0/4-2 cells. The leftmost lane of B contains size markers with 100-bp intervals and intensified bands at 500 bp and 1 kb. C, cells were treated with or without H2O2 at 1 mM together with DFX (closed bars). LDH activities in culture media released from each cell type (in milliunits, n = 3, mean ± S.D.) after a 24-h treatment were measured, and DNA from cells was electrophoresed as described above. The numbers between C and D indicate the concentrations of DFX (0-500 µM). Open bars in the left half and the right half of the graphs are LDH activity in the media of SILA and Srho -0/4-2 cells, respectively, without any treatment. ** and *** indicate a significant increase in LDH activity compared with each control (open bars) at p < 0.001 and < 0.0001, respectively. D, gel electrophoretic patterns of DNA isolated from SILA (left) and Srho -0/4-2 (right) cells. The 100-bp DNA ladder is shown in the leftmost lane in the D.

Determination of Iron-- ICP-MS revealed the concentration of iron in SILA and three Srho -0 clones, 1-6, 4-2, and 6H10, to be 124 ± 24, 395 ± 126, 359 ± 94, and 356 ± 23 ng/mg, respectively (Fig. 6, n = 4-5, *, p < 0.05).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 6.   Iron contents. Cells confluent in 10-cm diameter dishes were washed twice with phosphate buffer containing 0.25 M mannitol and reduced completely to ash, which was dissolved in 10 ml of 6% nitric acid. Cellular ashes were subjected to the ICP-MS. A standard curve for iron was obtained using a serially diluted metal standard, and the regression coefficient with a line was greater than p < 0.999 in all experiments. Total iron levels were standardized with cellular protein and are shown as ng/mg. Three Srho -0 clones (1-6, 4-2, 6H10, closed bars) contained more iron than SILA (open bar) cells (n = 4-6, mean ± S.E., *, p < 0.05).

Production of Normal Cybrid-- We could establish a normal and control cybrid line using Srho -0/1-6 cells as a recipient by fusing them with platelets from a healthy volunteer. Replenishment of the mtDNA in the rho -0 cells was evidenced by PCR (Fig. 7A, cybrid clones 1 and 2). Correspondingly, the lactate production by control cybrid clones 1 and 2 was similar to that of the parent cells, which was significantly lower than that of Srho -0 cells (Fig. 7B, n = 3, ***, p < 0.0001).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 7.   Generation of normal cybrids. Srho -0 cells were fused with platelets with polyethylene glycol and then plated in T25 flasks and allowed to grow in culture medium without pyruvate and uridine. After cells resistant to depletion of pyruvate and uridine became confluent, they were replated into 10-cm diameter dishes as described in the legend of Fig. 6 for determining the five different metals. Meanwhile, their DNA was also isolated using a standard procedure. A, PCR determination of replenishing mtDNA in normal cybrid clones 1 and 2. A beta -actin gene (act) was also amplified to evaluate the level of DNA (10 ng) targeted for the PCR. D-lp indicates the D-loop region in mtDNA. B, the lactate levels in culture media of SILA (open bar), Srho -0/1-6, and the two cybrid clones (closed bars) were evaluated with the kit. An elevation in the lactate production in Srho -0 cells (mean ± S.E., n = 3, ***, p < 0.0001) was no longer observed in the control cybrid cells, which were replenished with the normal mtDNA (cybrids 1 and 2) (mean ± S.E., n = 3, ***, p < 0.0001).

Measurement of Other Metals and Sensitivity to H2O2 in Parent, Srho -0, and Control Cybrids-- The levels of five metals, aluminum, iron, zinc, manganese, and copper were all found to be elevated significantly in Srho -0 clone 1-6 cells compared with the parent cells (Fig. 8, A and B). With the exception of the zinc levels, the other four metals in control cybrid cells were similar to those in parent cells. The levels of zinc in the cybrids also showed a decreasing trend. LDH release from parent, rho -0, and control cybrid cells (Fig. 8C, LDH, n = 3, ***, p < 0.001) and their morphologies (Fig. 8, D-F) after treatment with H2O2 at 0.5 mM for 24 h indicated that the sensitivity of the control cybrids to this treatment was similar to that of the parent cells, with Srho -0/1-6 cells being more sensitive than the other two cell types.


View larger version (71K):
[in this window]
[in a new window]
 
Fig. 8.   Comparison of three cell types in contents of five metals and sensitivity to H2O2. A and B, samples prepared for ICP-MS were applied to the ICP-8500 apparatus as described before. For this experiment we programmed it to measure five different metals in SILA (open bars), Srho -0/1-6 (closed bars), and the control cybrids (gray bars) sequentially (n = 4-6, mean ± S.E., *, p < 0.05, **, p < 0.001, ***, p < 0.0001, ANOVA with Bonferroni's multiple comparison). The metal contents were measured and standardized as described above and are shown as ng/mg. These metals were grouped into categories A and B because the basal levels of manganese and copper are about 1 order of magnitude different from those of aluminum, iron, and zinc. C, SILA (open bars), Srho -0/1-6 (closed bar) and the control cybrid (gray bar) cells were incubated with H2O2 at 0.5 mM for 24 h, and the LDH activities released into culture media were measured as described under "Experimental Procedures." The total LDH activities of cells without the treatment were also measured using the cell lysate. In this graph, LDH activities in the media were expressed as a percentage of the total cellular LDH activities of each line. *** indicates p < 0.0001 (n = 3, ANOVA with Bonferroni's multiple comparison). D-F, morphologies of SILA (D), Srho -0/1-6 (E), and control cybrid (F) cells after treatment with H2O2 at 0.5 mM for 24 h. The scale bar in F indicates 33 µm. Srho -0 cells were detached from the dish and shrank in morphology, whereas the parent and cybrid cells showed only a slight morphological change.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Given the considerable phenotypic differences among lines and because only one human neuroblastoma-derived rho -0 cell line (SH-SY5Y origin) is currently available (31), it becomes necessary to isolate additional rho -0 lines from nervous tissue for comparison. We established Srho -0 lines from human neuroblastoma-derived SILA cells to determine whether a deficiency in mitochondrial respiration renders cells susceptible to metal-mediated, oxidative stress.

It is expected, a priori, that rho -0 cells shift their energy metabolism from aerobic to anaerobic. That cybrid cells replenished with normal mtDNA produced lactate at the same level as the parent cells indicates that a glycolytic shift of rho -0 cells had taken place and that it is respiration state-dependent and reversible. These results are consistent with those reported by Vaillant et al. (36). It is not surprising that the ATP level of these respiration-lacking cells was at least not reduced compared with that of the parent cells when glycolysis was highly up-regulated to overcome the reduction of the cellular ATP. Cells of a glial nature, such as astrocytes and Schwann cells, are known to up-regulate glycolysis under ischemic conditions (37, 38). It is necessary to establish more rho -0 lines with neuronal or glial origin and compare them with each other to elucidate mechanisms by which cells adapt to the respiration-deficient state.

Electron microscopic observation of Srho -0 cells revealed swollen mitochondria with translucent matrix and quite irregular cristae structure, which were seen regardless of the clones. Unique onion-shaped concentric multilamellae-containing mitochondria are specific not only to the present rho -0 cells but were also observed in other rho -0 cells (39, 40). Progressive external opthalmoplegia and Kearn-Sayre syndrome, which are caused by deletion of mtDNA (41, 42), are known to develop similar morphological changes in the mitochondria in muscle tissues (43, 44). Heart muscles and other tissues affected with anoxia and ischemia (45, 46) and neurons whose mitochondrial respiration is inhibited with methyl mercury (47) also develop concentric lamellae and other types of mitochondrial morphologies as seen in the present and other rho -0 cells. Concentric lamellae-containing mitochondria could thus represent a morphological hallmark of impaired respiration of muscle and neuronal cells. Importantly, this structure was observed in brains of AD patients (48) as well as in rho -0 cells to which mtDNAs from AD patients were transferred (25). These findings suggest a strong association of mitochondrial impairment with the pathogenesis of AD. The number of abnormal mitochondria in Srho -0 cells seemed to be similar to that in the parent cells. However, it is necessary to determine precisely whether the number of mitochondria was altered in Srho -0 cells.

CMTMRos, a MitoTracker dye, which is a formaldehyde-resistant fluorochrome, is sensitive to Delta Psi m, unlike other MitoTrackers (49). The Delta Psi m of the present Srho -0 cells was reduced approximately 30-40% compared with the parent cell level. This result concurs with the report that the Delta Psi m of 143B-rho 0 cells is 80-90% less that than their parent cell level but is different from the result of rho -0 cells derived from HeLa S3, which showed no reduction (50). It is conceivable that even the pathological mitochondria found in the present Srho -0 cells still hold a reduced Delta Psi m because the F1-ATPase (50, 51) and the adenine nucleotide translocater (50) of mitochondria are still functional, at least in those reported rho -0 lines.

Mitochondrial abnormalities may be a final, common pathway leading to neuronal death in neurodegenerative disorders (12). To identify the consequences of chronic respiratory deficiency, we examined whether Srho -0 cells are susceptible to oxidative stress, another major factor in neurodegeneration (4, 9, 12, 14). LDH release and the DNA electrophoretic pattern of cells after incubation with the different concentration of H2O2 clearly demonstrated their hypersensitivity to this stress. We are unable to address the precise cell death mechanism only with these results, but as evidenced by nucleosomal DNA fragmentation and the smear DNA electrophoretic pattern, the parent SILA cells apparently underwent apoptosis, and Srho -0 cell death probably occurred through necrosis.

Cells are permeable to H2O2, which is converted into a highly toxic hydroxyl radical through a mechanism known as the Fenton and Haber-Weiss reaction when transition metals such as iron, copper, and zinc are present (4). Therefore, we hypothesized that these metals, particularly iron, are accumulated in Srho -0 cells. DFX is distinctly hydrophilic as the partition coefficients indicate (0.01 with iron and 0.03 without iron) (52). However, many researchers successfully utilized DFX to remove cellular iron/copper, relying on the fact that it influxes/effluxes across cell membranes in time- and dose-dependent and saturable manner (52). Coincubated together with H2O2, DFX completely abolished the parent cell death, whereas Srho -0 cell death was not suppressed, indicating an accumulation of iron and copper in these cells. An inhibitory effect on the SILA cell death was observed at DFX concentrations greater than 50 µM and a complete suppression at more than 200 µM. In Srho -0 cells, although we were unable to examine the effect of DFX at greater than 500 µM because of its toxicity, an accumulation of iron and other metals is therefore expected to be at least severalfold higher than that in the parent cells because DFX coordinates iron at the molar ratio 1:1 (52). Other explanations such as a decrease in the level of the antioxidant systems may also be likely. To seek out the underlying mechanisms, we first examined the total reduced GSH level in parent and Srho -0 cells and found that the levels in both these cell types were not significantly different from each other. We then evaluated the total cellular iron level in SILA and three Srho -0 clones using ICP-MS. This technique is highly sensitive and quantitative and is also applicable to any elements included in cells and tissues (8, 35). As expected, in all three Srho -0 clones, the iron contents were approximately 3-fold higher compared with the parent SILA cells. This is the first study to reveal an accumulation of iron in mtDNA-depleted cells. To clarify whether the H2O2-induced Srho -0 cell death is metal-dependent and whether accumulation of metals and cell-death is dependent on mtDNA, the levels of other transition metals in parent, rho -0, and the control cybrid cells and the sensitivity of these three cell types to H2O2 were evaluated. The contents of aluminum, zinc, manganese, and copper as well as iron were all elevated in Srho -0 cells compared with those of parent cells. These levels in the control cybrids were similar to the parent cell levels except for zinc, which nevertheless showed a decreasing trend. Moreover, unlike Srho -0 cells, the susceptibility of the control cybrid cells to H2O2 was as similar to that of the parent cells. These findings strongly suggest that both SILA and Srho -0 cell death include a metal-dependent mechanism and that accumulated transition metals in Srho -0 cells exacerbated the toxic effect of H2O2. Evaluation and comparison of contents of metals in other Srho -0 clones and rho -0 cells from other cell lines will be necessary to conclude whether the accumulation of metals shown above is reproducible. It is not surprising that an increase in the cellular iron is observed in an association with an increase of other metals because of the coupling of metabolisms of iron, copper, and other metals (2, 4, 9, 11, 53).

The evidence that the contents of metals in the control cybrid cells were similar to those in the parent cells suggests that iron accumulation is the result of impairment in mitochondrial respiration. Deficiency in mitochondrial Fe-S enzymes occurs in mitochondria in muscle tissues of mice, whose frataxin gene was genetically disrupted (21). Importantly, an impairment of the mitochondrial enzymes preceded an accumulation of iron in the tissue by several weeks. The substantia nigra and globus pallidus of the brain of patients with Parkinson's disease are known to accumulate iron (4, 9, 11), which is concomitant with the dysfunction of complex I (12). Moreover, in vulnerable regions of brains affected with AD, accumulation of iron and aluminum (5-9) and mitochondrial abnormalities (12, 14, 17-19) were also reported. It appears therefore plausible that the accumulation of iron and other metals repeatedly observed in brains with these neurodegenerative disorders could be caused by or at least coupled with mitochondrial impairment. Hence, it is important to elucidate the mechanisms of accumulation of metals in rho -0 cells.

In conclusion, we have prepared a novel rho -0 line from a human neuroblastoma SILA line with which complementary experiments are available. These mutant cells exhibit unique features including metabolic adaptation, altered mitochondrial morphologies, and reduced Delta Psi m. They were highly susceptible to oxidative stress likely because of an accumulation of iron and other metals. Some of these unique phenotypes are mtDNA-dependent because replenishment of rho -0 cells with normal mtDNA reversed the altered phenotypes. These phenotypes of newly established rho -0 cells resemble, in part, the phenotypes of some forms of mitochondrial and neurological diseases caused with or without alterations in mtDNA.

    ACKNOWLEDGEMENTS

We gratefully acknowledge Dr. Matsumura (Department of Pediatrics, Kyoto Prefectural University of Medicine) for generously donating the SILA cells. We also thank Dr. Sasaki (Positron Medical Center, Tokyo Metropolitan Institute of Gerontology), Dr. Yoneda (First Department of Internal Medicine, Fukui Medical University), and Dr. Chandrasekaran (Department of Anesthesiology, University of Maryland) for helpful discussions on the nature and energy metabolism of rho -0 cells. We thank Dr. A. D. Purdon for critical reading of the manuscript.

    FOOTNOTES

* This research was supported in part by Grant-in-aid H11-Chojyu-019 from the Japanese Foundation for Aging and Health and by the Ministry of Education, Culture, Sports, Science, and Technology of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Alzheimer Research Laboratory, Dept. of Neurosciences, Case Western Reserve University School of Medicine, E504, 10900 Euclid Ave., Cleveland, OH 44106-4928. Tel.: 216-368-3435; Fax: 216-368-3079; E-mail: rxf33@po.cwru.edu.

§§ Present address: Dept. of Cell Biology and Neuroscience, Graduate School of Medicine, Osaka University, Yamadaoka 2-2, Suita, Osaka 565-0871, Japan.

Published, JBC Papers in Press, August 22, 2002, DOI 10.1074/jbc.M204176200

    ABBREVIATIONS

The abbreviations used are: AD, Alzheimer's disease; ANOVA, analysis of variance; DFX, deferoxamine; EtBr, ethidium bromide; ICP-MS, inductively coupled plasma-mass spectrometry; LDH, lactate dehydrogenase; Delta Psi m, mitochondrial transmembrane potential; mtDNA, mitochondrial DNA.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., and Hayflick, S. J. (2001) Nat. Genet. 28, 345-349[CrossRef][Medline] [Order article via Infotrieve]
2. Waggoner, D. J., Bartnikas, T. B., and Gitlin, J. D. (1999) Neurobiol. Dis. 6, 221-230[CrossRef][Medline] [Order article via Infotrieve]
3. Delatycki, M. B., Camakaris, J., Brooks, H., Evans-Whipp, T., Thorburn, D. R., Williamson, R., and Forrest, S. M. (1999) Ann. Neurol. 45, 673-675[CrossRef][Medline] [Order article via Infotrieve]
4. Gutteridge, J. M. C. (1994) Ann. N. Y. Acad. Sci. 738, 201-213[CrossRef][Medline] [Order article via Infotrieve]
5. Loeffler, D. A., Connor, J. R., Juneau, P. L., Snyder, B. S., Kanaley, L., DeMaggio, A. J., Nguyen, H., Brickman, C. M., and LeWitt, P. A. (1995) J. Neurochem. 65, 710-716[Medline] [Order article via Infotrieve]
6. Diebel, M. A., Ehmann, W. D., and Markesbery, W. R. (1996) J. Neurol. Sci. 143, 137-142[CrossRef][Medline] [Order article via Infotrieve]
7. Beauchemin, D., and Kisilevsky, R. (1998) Anal. Chem. 70, 1026-1029[Medline] [Order article via Infotrieve]
8. Bartzokis, G., and Tishler, T. A. (2000) Cell. Mol. Biol. 46, 821-833[Medline] [Order article via Infotrieve]
9. Thompson, K. J., Shoham, S., and Connor, J. R. (2001) Brain Res. Bull. 55, 155-164[CrossRef][Medline] [Order article via Infotrieve]
10. Cuajungco, M. A., Faget, K. Y., Huang, X., Tanzi, R. E., and Bush, A. I. (2000) Ann. N. Y. Acad. Sci. 920, 292-304[Medline] [Order article via Infotrieve]
11. Berg, D., Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., and Becker, G. (2001) J. Neurochem. 79, 225-236[CrossRef][Medline] [Order article via Infotrieve]
12. Cassarino, D. S., and Bennett, J. P. (1999) Brain Res. Rev. 29, 1-25[CrossRef][Medline] [Order article via Infotrieve]
13. Smeitink, J., van den Heuvel, L., and DiMauro, S. (2001) Nature Rev. 2, 342-352
14. Bonilla, E., Tanji, K., Hirano, M., Vu, T. H., DiMauro, S., and Schon, E. A. (1999) Biochim. Biophys. Acta 1410, 171-182[Medline] [Order article via Infotrieve]
15. Fosslin, E. (2001) Ann. Clin. Lab. Sci. 31, 25-67[Abstract/Free Full Text]
16. Brennan, W. A., Bird, E. D., and Aprille, J. R. (1985) J. Neurochem. 44, 1948-1950[Medline] [Order article via Infotrieve]
17. Fukuyama, R., Hatanpää, K., Rapoport, S. I., and Chandrasekaran, K. (1996) Brain Res. 713, 290-293[CrossRef][Medline] [Order article via Infotrieve]
18. Aksenov, M. Y., Tucker, H. M., Nair, P., Aksenova, M. V., Butterfield, D. A., Estus, S., and Markesbery, W. R. (1999) Neurochem. Res. 24, 767-774[CrossRef][Medline] [Order article via Infotrieve]
19. Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., Shimohama, S., Cash, A. D., Siedlak, S. L., Harris, P. L. R., Jones, P. K., Peterson, R. B., Perry, G., and Smith, M. A. (2001) J. Neurosci. 21, 3017-3023[Abstract/Free Full Text]
20. Ristow, M., Pfister, M., Yee, J. A., Schubert, M., Michael, L., Zhang, C.-Y., Ueki, K., Michael, M. D., Jr., Lowell, B. B., and Kahn, C. R. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 12239-12243[Abstract/Free Full Text]
21. Puccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., and Koenig, M. (2001) Nat. Genet. 27, 181-186[CrossRef][Medline] [Order article via Infotrieve]
22. Green, D. R., and Reed, J. C. (1998) Science 281, 1309-1316[Abstract/Free Full Text]
23. King, M. P., and Attardi, G. (1989) Science 246, 500-503[Abstract/Free Full Text]
24. Chomyn, A., Lai, S. T., Shakeley, R., Bresoiln, N., Scarlato, G., and Attardi, G. (1994) Am. J. Hum. Genet. 54, 966-974[Medline] [Order article via Infotrieve]
25. Trimmer, P. A., Swerdlow, R. H., Parks, J. K., Keeney, P., Bennett, J. P., Miller, S. W., Davis, R. E., and Davis Parker, W. (2000) Exp. Neurol. 162, 37-50[CrossRef][Medline] [Order article via Infotrieve]
26. Kennedy, E. D., Maechler, P., and Wollheim, C. B. (1998) Diabetes 47, 374-380[Abstract]
27. Asoh, S., and Ohta, S. (1997) Biochem. Biophys. Res. Commun. 237, 659-662[CrossRef][Medline] [Order article via Infotrieve]
28. Jiang, S., Cai, J., Wallace, D. C., and Jones, D. P. (1999) J. Biol. Chem. 274, 29905-29911[Abstract/Free Full Text]
29. Martinus, R. D., Garth, G. P., Webster, T. L., Cartwright, P., Naylor, D. J., Høj, P. B., and Hoogenraad, N. J. (1996) Eur. J. Biochem. 240, 98-103[Medline] [Order article via Infotrieve]
30. Thomas, A. W., Majid, A., Sherratt, E. J., Gagg, J. W., and Alcolado, J. C. (1999) Clin. Sci. 97, 207-213[Medline] [Order article via Infotrieve]
31. Miller, S. W., Trimmer, P. A., Davis Parker, W., and Davis, R. E. (1996) J. Neurochem. 67, 1897-1907[Medline] [Order article via Infotrieve]
32. Matsumura, T., Sugimoto, T., Horii, Y., Kuroda, H., Saida, T., Hosoi, H., Michihata, T., Hino, T., Kawakatsu, H., Sawada, T., Inazawa, J., and Abe, T. (1989) Hum. Cell 2, 206-207[Medline] [Order article via Infotrieve]
33. Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., Schreier, P. H., Smith, A. J. H., Staden, R., and Young, I. G. (1981) Nature 290, 457-465[CrossRef][Medline] [Order article via Infotrieve]
34. Nakajima-Iijima, S., Hamada, H., Reddy, P., and Kakunaga, T. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 6133-6137[Abstract/Free Full Text]
35. Nakayama, A., Fukuda, H., Masaaki, E., Hamasaki, H., Nakajima, K., and Sakurai, H. (2002) Biol. Pharm. Bull. 25, 426-431[CrossRef][Medline] [Order article via Infotrieve]
36. Vaillant, F., Loveland, B. E., Nagley, P., and Linnane, A. W. (1991) Biochem. Int. 23, 571-580[Medline] [Order article via Infotrieve]
37. Stewart, M. A., Passonneau, J. V., and Lowry, O. H. (1965) J. Neurochem. 12, 719-727[CrossRef][Medline] [Order article via Infotrieve]
38. Marrif, H., and Juurlink, B. H. J. (1999) J. Neurosci. Res. 57, 255-260[CrossRef][Medline] [Order article via Infotrieve]
39. Soslau, G., and Nass, M. M. K. (1971) J. Cell Biol. 51, 514-524[Abstract/Free Full Text]
40. Morais, R. (1980) J. Cell. Physiol. 103, 455-466[CrossRef][Medline] [Order article via Infotrieve]
41. Moraes, C. T., DiMauro, S., Zeviani, M., Lombes, A., Shanske, S., Miranda, A. F., Nakase, H., Bonilla, E., Werneck, L. C., Servidei, S., Nonaka, I., Koga, Y., Spiro, A. J., Brownell, A. K. W., Schmidt, B., Schotland, D. L., Zupanc, M., DeVivo, D. C., Schon, E. A., and Rowland, L. P. (1989) N. Engl. J. Med. 320, 1293-1299[Abstract]
42. Saiwaki, T., Shiga, K., Fukuyama, R., Tsutsumi, Y., and Fushiki, S. (2000) J. Clin. Pathol. Mol. Pathol. 53, 333-335[Abstract/Free Full Text]
43. Schwartzkopff, B., Frenzel, H., Breithardt, G., Deckert, M., Lösse, B., Toyka, K. V., Borggrefe, M., and Hort, W. (1988) J. Am. Col. Cardiol. 12, 1522-1528[Abstract]
44. van Domburg, P. H. M. F., GabreUels-Festen, A. A. W. M., GabreUels, F. J. M., de Coo, R., Ruitenbeek, W., Wesseling, P., and ter Laak, H. (1996) Brain 199, 997-1010
45. Hug, G., and Schubert, W. K. (1970) Lab. Invest. 22, 541-552[Medline] [Order article via Infotrieve]
46. Schwartzkopff, B., Zierz, S., Frenzel, H., Block, M., Neuen-Jacob, E., Reiners, K., and Strauer, B. E. (1991) Virchows Arch. A Pathol. Anat. 419, 63-68[CrossRef]
47. O'Kusky, J. (1983) Acta Neuropathol. 61, 116-122[CrossRef][Medline] [Order article via Infotrieve]
48. Baloyannis, K. (2000) Neurobiol. Aging 21, S264
49. Macho, A., Decaudin, D., Castedo, M., Hirsch, T., Susin, S. A., Zamzami, N., and Kroemer, G. (1996) Cytometry 25, 333-340[CrossRef][Medline] [Order article via Infotrieve]
50. Buche, K., and Godinot, C. (1998) J. Biol. Chem. 273, 22983-22989[Abstract/Free Full Text]
51. García, J. J., Ogilvie, I., Robinson, B. H., and Capaldi, R. A. (2000) J. Biol. Chem. 275, 11075-11081[Abstract/Free Full Text]
52. Porter, J. B., Gyparaki, M., Burke, L. C., Huehns, E. R., Sarpong, P., Saez, V., and Hider, R. C. (1988) Blood 72, 1497-1503[Abstract/Free Full Text]
53. Harris, Z. L., Durley, A. P., Man, T. K., and Gitlin, J. D. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 10812-10817[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/44/41455    most recent
M204176200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuyama, R.
Right arrow Articles by Fushiki, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuyama, R.
Right arrow Articles by Fushiki, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement